Preliminary Conference Programme

Wednesday 7 July 2021

10:00 - 11:00

Virtual exhibition & networking

11:00

Conference opening remarks

Dr Peter GREEN (Chairman, HEART UK)

 

Session 1: Lp(a)… what does it mean ?

11:00 - 11:20

Lp(a) measurement bias 

Over and underestimation of Lp(a) due to its different molecular weight isoforms has led to bias in many studies leading to underestimation of its strength as a cardiovascular risk factor

Dr Mike FRANCE (Manchester, UK)

11:20 - 11:40

How does Lp(a) fit with FH

Prof Paul DURRINGTON (Manchester, UK)

11:40 - 12:15

The role of Lp(a) and oxPLs in atherosclerosis

Current and future therapeutic agents and interventions targeting Lp(a) and oxPLs

Prof Sam TSIMIKAS (San Diego, USA)

12:15 - 12:30

Break, virtual exhibition & networking

 

Session 2: Hyperlipidaemia educational updates

12:30 - 12:50

Cardiac CT; the future of imaging

Why cardiac CT is useful for those with patients with raised cholesterol

Dr Derek CONNOLLY (Birmingham, UK)

12:50 - 13:10

Urine chemical medication analysis in the assessment of medication adherence

The presentation will cover the  how, the why and the when of using the test

Dr Pankaj GUPTA (Leicester, UK)

13:10 - 13:30

The impact of metabolic surgery on obesity related dyslipidaemia

Dr Safwaan ADAM (Manchester, UK)

13:30 - 14:15

Lunch, virtual exhibition & networking

 

Session 3: FH or not?

14:15 - 15:55

Introduction and Interactive cases linked to 

Ms Kate HARALAMBOS (Cardiff, Wales, UK)


Polygenic hypercholesterolaemia: why do we want to know?
How knowing that a patient with clinical FH has a polygenic and not a monogenic cause for their phenotype is key in the clinician deciding on the appropriate patient care pathway

Prof Steve HUMPHRIES (London, UK)


VUS in FH

Dr Maggie WILLIAMS (Bristol, UK)

14:55 - 15:15

Break, virtual exhibition & networking

15:15 - 16:15

Session 4: Myant lecture:

Familial Hypercholesterolaemia: from Epidemiology to Genetics – a paradigm shift?

Clinical Certainties and Uncertainties: what remains unresolved?

Prof Andrew NEIL (Oxford, UK)

16:15

Day one close

Tuesday 13 July 2021

14:45 - 15:30

Virtual exhibition & networking

 

Session 5: Oral abstract session


Submit an abstract

15:30 - 16:20

Medical & Scientific - Abstracts of free communications x 5

16:20 - 17:10

Primary & Health Care - Abstracts of free communications x 5

17:10 - 17:25

Break, virtual exhibition & networking

17:25 - 17:30

Presentation of certificates to oral abstract winners x 2

17:30 - 18:00

Sponsored symposium 1: 

Hosted by

18:00

Day two close

Thursday 15 July 2021

15:15 - 16:00

Virtual exhibition & networking

16:00 - 16:30

Moderated poster session

Submit an abstract

 

Session 6:  

16:30 - 16:50

Considering CVD and the menopause

Ms Lynne INNES (Edinburgh, Scotland, UK)

16:50 - 17:10

Saturated fat report

Prof Ian YOUNG (Belfast, N Ireland)

17:10 - 17:25

Break, virtual exhibition & networking

17:25 - 17:30

Presentation of prizes to
- Rhianna Wingett award winner
- Poster abstract winners

17:30 - 18:00

Sponsored symposium 2

18:00

Day two close

Tuesday 20 July 2021

15:00 - 15:45

Virtual exhibition & networking

 

Session 7: Primary Care + Allied Health Professionals session

15:45 - 16:00

An introduction to the basics of cholesterol 

16:00 - 16:15

Understanding cholesterol results 

16:15 - 16:30

The impact of diet on cholesterol 

16:30 - 16:45

Analysing food 

16:45 - 17:00

Diabetes, diet and cholesterol/SACN low carb

17:00 - 17:15

N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects: The SAMSON Trial

60 patients with previous statin side effects were given alternating periods of statin, placebo and no treatment to determine what proportion of their side effects are due to the nocebo effect.

Dr James HOWARD (London, UK)

17:15 - 17:30

Break, virtual exhibition & networking

17:30 - 18:00

Sponsored symposium 3

18:00

Day three close

Thursday 22 July 2021

15:00 - 15:25

Virtual exhibition & networking

15:25 - 15:30

Introduction

15:30 - 16:30

Sponsored symposia 4
Part 1: Hosted by

 

Part 2: Hosted by 

 

16:30 - 16:45

Break, virtual exhibition & networking

 

Session 8: Scientific session + hot topics

16:45 - 16:50

Introduction 

16:50 - 17:10

Covid talk

17:10 - 17:30

NICE Guidelines and Technology Appraisals: How Does it Work?

Overview of the processes by which NICE devises guidelines, does drug technology and diagnostic assay appraisals.

Prof Tony WIERZBICKI (London, UK)

17:30 - 17:50

The long term plan and FH targets – what activities are going on to get it there

Prof Nick LINKER (London, UK)

17:50 - 18:00

Conference closing remarks

Dr Peter GREEN (Chairman, HEART UK)
Day four close

Provisional programme. The organisers reserve the right to change the programme at any time.